News

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.
New epinephrine nasal spray dosage approved for pediatrics; FDA agree to review semaglutide for weight management; wearable defibrillator cleared to ...
In a recent study, protective association lasted for up to eight years, with greatest reduction seen at two to three years postvaccination.
Increased risk for attacks seen in women younger than 35 years, those with eosinophilia, those with lower corticosteroid use.
Terminations resulted in $1.81 billion in terminated grant funding; 30% had not been expended at time of termination.
HealthDay News — North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge, the Associated Press is reporting.
The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...
The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.
Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.
Introduction of pregnancy checkbox associated with increase in reported maternal mortality of 6.78 deaths per 100,000 livebirths.
HealthDay News — A quality improvement program can improve recommended antibiotic duration in children for both acute otitis media (AOM) and community-acquired pneumonia (CAP) across multiple care ...
The US Food and Drug Administration has chosen Dr Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.